Press – Maiwald

Press Coverage

10 Sep 2024 - Press Coverage

Sanofi cabazitaxel patent revoked by Paris court

In the ongoing case between Sanofi and the generic drug manufacturer Accord, the Paris Judicial Court has fully revoked Sanofi’s patent for the chemotherapy drug Jevtana. The patent EP 2 493 466, which protects a new use of cabazitaxel in combination with prednisone or pre...

22 May 2024 - Press Coverage

Royalty Pharma and Cytokinetics Announce Expanded Strategic Funding Collaboration Totaling up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline

Deal provides Cytokinetics with diversified access to capital as company advances its specialty cardiology franchise NEW YORK, NY and SOUTH SAN FRANCISCO, CA, May 22, 2024 – Royalty Phar...

9 May 2024 - Press Coverage

Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab

Frexalimab is in Phase 3 development by Sanofi in multiple sclerosis with multi-blockbuster potential in a wide range of immune-mediated diseases Expands Royalty Pharma’s ...

All press coverage

Maiwald press releases

11 Aug 2023 - Press Release

Another success for Maiwald and betapharm Arzneimittel GmbH

We are happy to report that the oppositions filed by our client betapharm and eight other generics manufacturers against Novartis patent EP 3 351 246 were successful; the Board of Appeal of the European Patent Office revoked the Novartis patent for lack of inventive step (fi...

20 Dec 2022 - Press Release

Maiwald wins important opposition case for its client Acetate International LLC at the European Patent Office

Maiwald GmbH in Munich has achieved an important victory for its client Acetate International LLC at the European Patent Office. Acetate International LLC is part of the Celanese group which has a long history of producing cellulose acetate products for commercial applicatio...

11 Oct 2022 - Press Release

Law firm will in future operate as Maiwald GmbH

Munich, 11 October 2022 - Maiwald, one of Germany's largest and most renowned law firms in the field of intellectual property, will in future operate under a new name: Effective October 11, 2022, Maiwald Patentanwaltsgesellschaft und Rechtsanwaltsgesellschaft mbH changed its...

All press releases

Maiwald in the press